Product
Olinvacimab
1 clinical trial
1 indication
Indication
Colorectal Cancer MetastaticClinical trial
A Phase lb/ll, Multicenter, Open Label, Single Arm Study to Assess the Safety and Efficacy of the Anti-VEGFR2 Monoclonal Antibody Olinvacimab and the Capecitabine in Patients With mCRC Who Failed Two Prior ChemotherapiesStatus: Withdrawn, Estimated PCD: 2023-10-31